Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 70Breast Neoplasms 52Ovarian Neoplasms 43Lung Neoplasms 24Neoplasms 21Neoplasm Metastasis 20Fallopian Tube Neoplasms 20Carcinoma, Ovarian Epithelial 18Triple Negative Breast Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Uterine Cervical Neoplasms 9Head and Neck Neoplasms 9Stomach Neoplasms 8Recurrence 8Endometrial Neoplasms 8Adenocarcinoma of Lung 8Melanoma 7Esophageal Neoplasms 6Urinary Bladder Neoplasms 5Pancreatic Neoplasms 5Uterine Neoplasms 4Solid Tumors 4Small Cell Lung Carcinoma 4Prostatic Neoplasms 4Adenocarcinoma, Bronchiolo-Alveolar 4Adenocarcinoma Of Esophagus 4Thoracic Neoplasms 3Testicular Neoplasms 3Solid Tumor 3Sarcoma 3

Interventions

pembrolizumab 3Nivolumab 3Ipilimumab 3Cyclophosphamide 3Radiosurgery 2MART-1 Antigen 2CTLA-4 Antigen 2ulixertinib 1sotrastaurin 1siremadlin 1relatlimab 1pentetreotide 1oblimersen 1incomplete Freund's adjuvant 1fotemustine 1fludarabine phosphate 1fludarabine 1entrectinib 1defactinib 1binimetinib 1benzamide 1aldesleukin 1aflibercept 1Valacyclovir 1Toll-Like Receptor 1 1TYRP1 protein, human 1Sunitinib 1Standard of Care 1RO5126766 1RNA, Messenger 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Uveal Melanoma × Paclitaxel × Clear all
NCT01200342 2016-02-11

Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma

M.D. Anderson Cancer Center

Phase 2 Terminated
7 enrolled 3 charts
Dermatologic

Uveal Melanoma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡